News & Events

Gilead’s HIV Drug Reimbursement Cut Will be Devastating, 340B Covered Entities Say

Drug manufacturer Gilead recently announced that a huge cut in pharmacy reimbursement for its HIV and hepatitis B medicines that uninsured individuals get for free

13 Apr 2021

NY State 340B Providers Get More Time to Challenge Reimbursement Change

On April 6th, 2021, the New York legislature announced that it was delaying a controversial policy that would require the New York Medicaid program to

9 Apr 2021

226 Members of Congress Call on HHS Secretary to Protect 340B Program

Representative Spanberger issued a press release yesterday announcing that she and 225 of her colleagues sent a letter to Acting HHS Secretary Norris Cochran, asking

2 Mar 2021

At-Risk Communities Need a Covid Hero to Protect Critical Federal Resources

The following article was originally published by the Gotham Gazette.

Governor Cuomo has worked hard to cultivate a national reputation as the Emmy Award-winning hero of

18 Feb 2021

‘Nightmare scenario’: State cuts could impact HIV/AIDS patients across region

The following article was originally posted in Drug Channels on WETM TV 18’s website, https://www.mytwintiers.com, on December 10, 2020.  Trillium Health is an RWC-340B Sustaining

12 Dec 2020

Novo Nordisk and United Therapeutics Are the Latest Drug Manufacturers to Limit Access to 340B Prices at Contract Pharmacies

On December 1, 2020, drug manufacturer Novo Nordisk Inc. announced that, effective January 1, 2021, it “will no longer facilitate ‘bill-to/ship-to’ distribution of 340B product

3 Dec 2020

Press Release: RWC-340B and 340B Covered Entity Plaintiffs Ask Secretary of HHS to Immediately Enforce Covered Entities’ Rights Under 340B Statute

Washington, D.C. – On November 23, 2020, Ryan White Clinics for 340B Access (RWC-340B) and five 340B providers filed a motion in the United States

24 Nov 2020

217 Congressional Representatives Send Letter to Secretary Azar Opposing the Kalderos Rebate Model

Thanks to efforts by RWC-340B members and other covered entity advocates, 217 members of the House of Representatives signed a bipartisan letter to Health and

13 Nov 2020

Novartis Takes a Less Restrictive Approach to 340B Pricing at Contract Pharmacies

By letter dated October 30, 2020, Novartis is notifying covered entities that are federal grantees that they will continue to receive 340B discounts at contract

2 Nov 2020

RWC-340B/CV340B National Advocacy Webinar

Please join us for the Community Voices for 340B and Ryan White Clinics for 340B Access’ National Advocacy Webinar

RSVP by clicking HERE.
Webinar Description

The National Advocacy

29 Oct 2020
Top